Succelerate AG

Transforming healthcare through strategic innovation 🚀
Global expertise 🌍 | AI-powered solutions 🧠| Private and Public healthcare sector' partnerships 🤝

[Succelerate AG @succelerat1023]

Harnessing Opportunities: The Middle East and Africa Pharma Market.
In this week´s newsletter, we explore the trends driving its growth and increasing interest from the pharmaceutical industry, positioning MEA as a future global pharma powerhouse.
https://t.co/Jnzccseeu0

[Succelerate AG @succelerat1023]

This week's newsletter dives into Companion Nutrition Products - A Winning Strategy.
Discover key strategies for bridging nutrition and medical treatment, and access a case study showcasing our approach with a companion product for cancer treatment.
https://t.co/0MPw0DsQZg

[Succelerate AG @succelerat1023]

Explore our recommendations for navigating the challenges posed by the Inflation Reduction Act in the US #healthcare ecosystem.
➡️𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿: https://t.co/7V7n8RJtTz

#IRA #USA #pricing #valuebasedsolutions

[Succelerate AG @succelerat1023]

Are you prepared for the upcoming EU HTA Regulation impacting access to innovative #oncologytreatments? This week's newsletter dives into a recent report commissioned by @EFPIA on the #JCA process, a key pillar of the regulation.
➡️https://t.co/aV5IE7WNyK

[Succelerate AG @succelerat1023]

📰 Don't Miss Out!
The Latest Trends in Market Access, Pricing, and Evidence: A Recap of the EPA Congress 2024

@succelerat1023 was there, and we've curated the most crucial insights into our latest newsletter.
https://t.co/9RZUuP5s2C

[Succelerate AG @succelerat1023]

🥳💪🏻🌍𝗛𝗮𝗽𝗽𝘆 #InternationalWomensDay !
Let's continue to 𝗯𝗿𝗲𝗮𝗸 𝗱𝗼𝘄𝗻 𝗯𝗮𝗿𝗿𝗶𝗲𝗿𝘀, 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝘀𝘁𝗲𝗿𝗲𝗼𝘁𝘆𝗽𝗲𝘀, 𝗮𝗻𝗱 𝗮𝗱𝘃𝗼𝗰𝗮𝘁𝗲 𝗳𝗼𝗿 𝗴𝗲𝗻𝗱𝗲𝗿 𝗲𝗾𝘂𝗮𝗹𝗶𝘁𝘆 in the workplace and beyond.

#GenderEquality #WomenInHealthcare

[Succelerate AG @succelerat1023]

𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝗻𝗼𝘄:

𝗦𝘂𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀! 
𝗬𝗼𝘂𝗿 𝗼𝗻𝗲-𝘀𝘁𝗼𝗽 𝗱𝗲𝘀𝘁𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝘀𝘁𝗮𝘆𝗶𝗻𝗴 𝗮𝗵𝗲𝗮𝗱 𝗼𝗳 𝘁𝗵𝗲 𝗰𝘂𝗿𝘃𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗲𝘃𝗲𝗿-𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲.

https://t.co/5c4D6HSTZF

[Succelerate AG @succelerat1023]

Do you want to be part of a growing team, learn from the innovative companies and get high rewards, join the team in Succelerate and grow with them. Come join us+
https://t.co/WCbiFdBHDV

[Succelerate AG @succelerat1023]

@AstellasUS Eye-disease sometimes do not get the attention it requires, many patients and families struggles because of lack of support, glad to see companies raising awareness about this topic. At Succelerate, we help companies launch innovation as we have local healthcare system knowledge

[Succelerate AG @succelerat1023]

@AlexionPharma Rare Diseases are greatly underserved, huge steps were made to help patients, but more need to be done. We help companies to launch Rare and Ultra Rare disease globally with our local knowledge and strategic experience. Let us help you reach more patients!

[Succelerate AG @succelerat1023]

@AbtSwitzerland Ahh would love to try this! The beautiful Switzerland!

[Succelerate AG @succelerat1023]

@PMLiVEcom Great to hear, this is a very rare condition and patients need all the support they can get.. fingers crossed to get the final product soon #SuccelerateATTR

[Succelerate AG @succelerat1023]

Artificial Intelligence is supporting collection of data for any new medical product launch. we have in collaboration with HEAPS an AI platform that include 2 Million patients data and growing. Reach to us to Succelerate to discuss your needs and how we can help

[Succelerate AG @succelerat1023]

𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗨𝗻𝗶𝗼𝗻 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 (𝗘𝗨𝗻𝗲𝘁𝗛𝗧𝗔), companies need to understand how to submit and how it will be assessed, we have experience in the process and we can help! https://t.co/TaPMNYThCK

[Succelerate AG @succelerat1023]

#Succeleratejobs

[Succelerate AG @succelerat1023]

Check out this job from Succelerate AG https://t.co/HjojzBj7fR

A commission ONLY job, but it pays up to 40% commission depending on the size of the deal. We do not sponsor visa or pay any benefits also. if you are serious and has healthcare industry connection, please apply

[Succelerate AG @succelerat1023]

Rare Disease (Orpah and Ultra-Orphans) required a full Multi-stakeholders engagement plan. The team needs a strong understanding of the target patients, payers and physicians. Succelerate has extensive experience in supporting companies to launch Rare Disease globally!

[Succelerate AG @succelerat1023]

Reach to us if you wish to discuss further!

[Succelerate AG @succelerat1023]

The International Recognition Procedure (IRP) is a new regulatory framework that was introduced in the UK on January 1, 2024, to replace the EC Decision Reliance Procedure (ECDRP).
https://t.co/SxIcP1JmRU

[Succelerate AG @succelerat1023]

@FiercePharma Negotiation is going to be tough, if ICER is involved, more technical expertise will be required for the US to work around the HE modelling details.